$BMTM
Bright Mountain Media, Inc.

2023 Q3 Form 10-Q Financial Statement

#000162828023029384 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $15.29M $12.62M
YoY Change 191.55% 120.68%
Cost Of Revenue $11.93M $9.162M
YoY Change 284.99% 216.01%
Gross Profit $3.362M $3.454M
YoY Change 56.66% 22.59%
Gross Profit Margin 21.99% 27.38%
Selling, General & Admin $4.121M $7.374M
YoY Change 24.01% 114.16%
% of Gross Profit 122.58% 213.49%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $860.0K $767.0K
YoY Change 115.46% 8957.63%
% of Gross Profit 25.58% 22.21%
Operating Expenses $4.121M $7.374M
YoY Change 24.01% 114.16%
Operating Profit -$17.02M -$3.920M
YoY Change 1345.88% 526.49%
Interest Expense -$8.000K -$2.254M
YoY Change -98.95% 151.43%
% of Operating Profit
Other Income/Expense, Net -$2.749M -$2.151M
YoY Change 270.99% 282.87%
Pretax Income -$19.77M -$6.071M
YoY Change 930.6% 411.23%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$19.77M -$6.071M
YoY Change 930.6% 411.23%
Net Earnings / Revenue -129.29% -48.12%
Basic Earnings Per Share -$0.12 -$0.04
Diluted Earnings Per Share -$0.12 -$0.04
COMMON SHARES
Basic Shares Outstanding 171.3M shares 171.2M shares
Diluted Shares Outstanding 171.3M shares 166.8M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.780M $3.350M
YoY Change 574.76% 702.99%
Cash & Equivalents $2.780M $3.400M
Short-Term Investments
Other Short-Term Assets $810.0K $1.423M
YoY Change 5.33% 85.77%
Inventory
Prepaid Expenses $1.000M $1.610M
Receivables $16.16M $15.23M
Other Receivables $0.00 $0.00
Total Short-Term Assets $19.75M $20.00M
YoY Change 288.48% 326.45%
LONG-TERM ASSETS
Property, Plant & Equipment $176.0K $214.0K
YoY Change 375.68% 296.72%
Goodwill $8.349M $20.94M
YoY Change -57.5% 6.57%
Intangibles $16.19M $19.56M
YoY Change 230.86%
Long-Term Investments
YoY Change
Other Assets $187.0K $187.0K
YoY Change -22.08% -21.16%
Total Long-Term Assets $25.22M $41.23M
YoY Change 0.09% 58.51%
TOTAL ASSETS
Total Short-Term Assets $19.75M $20.00M
Total Long-Term Assets $25.22M $41.23M
Total Assets $44.98M $61.23M
YoY Change 48.51% 99.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.41M $11.14M
YoY Change 35.53% 30.72%
Accrued Expenses $370.0K $736.0K
YoY Change -84.94% -74.06%
Deferred Revenue $4.489M $4.863M
YoY Change 350.7% 679.79%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $4.790M $4.123M
YoY Change 69.14%
Total Short-Term Liabilities $28.39M $29.01M
YoY Change 59.29% 65.8%
LONG-TERM LIABILITIES
Long-Term Debt $56.72M $53.06M
YoY Change 139.87% 139.16%
Other Long-Term Liabilities $364.0K $276.0K
YoY Change 9.31% -60.08%
Total Long-Term Liabilities $364.0K $53.34M
YoY Change -98.48% 133.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $28.39M $29.01M
Total Long-Term Liabilities $364.0K $53.34M
Total Liabilities $85.75M $82.35M
YoY Change 105.12% 103.95%
SHAREHOLDERS EQUITY
Retained Earnings -$143.9M -$124.1M
YoY Change 29.17% 13.39%
Common Stock $1.721M $1.721M
YoY Change 14.73% 14.75%
Preferred Stock
YoY Change
Treasury Stock (at cost) $220.0K $220.0K
YoY Change 0.0% 0.07%
Treasury Stock Shares 825.2K shares 825.2K shares
Shareholders Equity -$40.77M -$21.12M
YoY Change
Total Liabilities & Shareholders Equity $44.98M $61.23M
YoY Change 48.51% 99.44%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$19.77M -$6.071M
YoY Change 930.6% 411.23%
Depreciation, Depletion And Amortization $860.0K $767.0K
YoY Change 115.46% 8957.63%
Cash From Operating Activities -$2.290M -$2.563M
YoY Change 335.87% 93.58%
INVESTING ACTIVITIES
Capital Expenditures $10.00K -$1.000K
YoY Change 161.78% -73.82%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$10.00K $1.000K
YoY Change -361.78% -126.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.730M 5.127M
YoY Change 234.82% 338.31%
NET CHANGE
Cash From Operating Activities -2.290M -2.563M
Cash From Investing Activities -10.00K 1.000K
Cash From Financing Activities 1.730M 5.127M
Net Change In Cash -570.0K 2.565M
YoY Change 11604.31% -1722.39%
FREE CASH FLOW
Cash From Operating Activities -$2.290M -$2.563M
Capital Expenditures $10.00K -$1.000K
Free Cash Flow -$2.300M -$2.562M
YoY Change 334.61% 94.07%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Depreciation
Depreciation
12000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
0 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
615000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
786000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
6626000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
2700000 usd
bmtm Service Agreement Period
ServiceAgreementPeriod
P5Y0M0D
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
276000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
319000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
82348000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
43271000 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
324000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
324000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
172106629 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
150444636 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
171281454 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
149619461 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
1721000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1504000 usd
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
825175 shares
CY2023Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
825175 shares
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
220000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
220000 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
101266000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
98797000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-124136000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-114269000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
250000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
117000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-21119000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-14071000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
61229000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29200000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12616000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5717000 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
9162000 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
2900000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
3454000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
2817000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3920000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-626000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-6820000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2745000 usd
CY2023Q2 bmtm Gain On Forgiveness Of Ppp Loan
GainOnForgivenessOfPppLoan
0 usd
CY2022Q2 bmtm Gain On Forgiveness Of Ppp Loan
GainOnForgivenessOfPppLoan
296000 usd
bmtm Gain On Forgiveness Of Ppp Loan
GainOnForgivenessOfPppLoan
0 usd
bmtm Gain On Forgiveness Of Ppp Loan
GainOnForgivenessOfPppLoan
1137000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
103000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
39000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2151000 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-832000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6071000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1458000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
0 usd
CY2022Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1000 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
0 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
2000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6071000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1459000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9867000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3577000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
119000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
17000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
133000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
17000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5952000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1442000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9734000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3560000 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
166779390 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
166779390 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
149159461 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
149159461 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
158291304 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
158291304 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-14071000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
31000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
25000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
14000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-17797000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-6071000 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1926000 usd
CY2023Q2 bmtm Adjustments To Additional Paid In Capital Extinguishment Of Debt
AdjustmentsToAdditionalPaidInCapitalExtinguishmentOfDebt
670000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
33000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
119000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-21119000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-6724000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2117000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
-1000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
29000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
279000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-8534000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1458000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
-1000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
30000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
17000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-9946000 usd
us-gaap Net Income Loss
NetIncomeLoss
-9867000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3575000 usd
us-gaap Depreciation
Depreciation
46000 usd
bmtm Noncash Interest Paid In Kind
NoncashInterestPaidInKind
2407000 usd
bmtm Noncash Interest Paid In Kind
NoncashInterestPaidInKind
0 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
29000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
844000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1114000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
58000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
59000 usd
bmtm Stock Compensation For Oceanside Shares
StockCompensationForOceansideShares
0 usd
bmtm Stock Compensation For Oceanside Shares
StockCompensationForOceansideShares
117000 usd
bmtm Gain On Forgiveness Of Ppp Loan
GainOnForgivenessOfPppLoan
0 usd
bmtm Gain On Forgiveness Of Ppp Loan
GainOnForgivenessOfPppLoan
1137000 usd
bmtm Common Stock Issued For Services Rendered
CommonStockIssuedForServicesRendered
31000 usd
bmtm Common Stock Issued For Services Rendered
CommonStockIssuedForServicesRendered
0 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-27000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3259000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
146000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
78000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-324000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-24000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
4000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2259000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-950000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1496000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
0 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-627000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-539000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3594000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2814000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
bmtm Payments For Proceeds From Dividend Payments
PaymentsForProceedsFromDividendPayments
0 usd
bmtm Payments For Proceeds From Dividend Payments
PaymentsForProceedsFromDividendPayments
2000 usd
bmtm Proceeds From Repayments Of Notes Receivable
ProceedsFromRepaymentsOfNotesReceivable
0 usd
bmtm Proceeds From Repayments Of Notes Receivable
ProceedsFromRepaymentsOfNotesReceivable
6000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
0 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
250000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6627000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2454000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3034000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-364000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
316000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
781000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3350000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
417000 usd
us-gaap Interest Paid Net
InterestPaidNet
161000 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
bmtm Noncash Interest Paid In Kind
NoncashInterestPaidInKind
2407000 usd
bmtm Noncash Interest Paid In Kind
NoncashInterestPaidInKind
0 usd
bmtm Non Cash Activity Recognition Of Right Of Use Asset And Operating Lease Liability
NonCashActivityRecognitionOfRightOfUseAssetAndOperatingLeaseLiability
0 usd
bmtm Non Cash Activity Recognition Of Right Of Use Asset And Operating Lease Liability
NonCashActivityRecognitionOfRightOfUseAssetAndOperatingLeaseLiability
691000 usd
bmtm Non Cash Activity Issuance Of Common Shares To Settle Share Liability
NonCashActivityIssuanceOfCommonSharesToSettleShareLiability
0 usd
bmtm Non Cash Activity Issuance Of Common Shares To Settle Share Liability
NonCashActivityIssuanceOfCommonSharesToSettleShareLiability
162000 usd
us-gaap Stock Issued1
StockIssued1
1926000 usd
us-gaap Stock Issued1
StockIssued1
0 usd
bmtm Noncash Activity Issuance Of Debt For Acquisition Financing
NoncashActivityIssuanceOfDebtForAcquisitionFinancing
19874000 usd
bmtm Noncash Activity Issuance Of Debt For Acquisition Financing
NoncashActivityIssuanceOfDebtForAcquisitionFinancing
0 usd
bmtm Line Of Credit Facility Interest Rate During Period Cash
LineOfCreditFacilityInterestRateDuringPeriodCash
0.05
us-gaap Line Of Credit Facility Interest Rate During Period
LineOfCreditFacilityInterestRateDuringPeriod
0.10
CY2023Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
21401993 shares
CY2023Q2 us-gaap Restructuring And Related Cost Expected Number Of Positions Eliminated
RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated
12 employee
us-gaap Restructuring And Related Cost Expected Number Of Positions Eliminated
RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated
17 employee
CY2023Q2 us-gaap Restructuring Charges
RestructuringCharges
114000 usd
us-gaap Restructuring Charges
RestructuringCharges
236000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-124100000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3600000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2800000 usd
bmtm Working Capital Deficit
WorkingCapitalDeficit
9000000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3400000 usd
CY2023Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
2900000 usd
CY2022Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
66000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make certain estimates, judgments and assumptions. We believe that the estimates, judgments and assumptions upon which we rely are reasonable based upon information available to us at the time that these estimates, judgments and assumptions are made. These estimates, judgments, and assumptions can affect the reported amounts of assets and liabilities as of the date of our unaudited consolidated financial statements as well as reported amounts of revenue and expenses during the periods presented. Our unaudited consolidated financial statements would be affected to the extent there are material differences between these estimates and actual results. In many cases, the accounting treatment of a particular transaction is specifically dictated by GAAP and does not require management’s judgment in its application. There are also areas in which management’s judgment in selecting any available alternative would not produce a materially different result.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Significant estimates included in the accompanying unaudited consolidated financial statements include, valuation of goodwill and intangible assets, estimates of amortization period for intangible assets, estimates of depreciation period for property and equipment, the valuation of equity-based transactions, valuation of the Center Lane Senior Secured Facility carrying value regarding debt modification or extinguishment,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and the valuation allowance on deferred tax assets.</span></div>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
Concentrations of Credit Risk<div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Financial instruments that potentially subject us to concentration of credit risk consist principally of cash and cash equivalents and accounts receivable. We place our cash and cash equivalents with high credit-quality financial institutions. Such deposits may be in excess of federally insured limits. In addition, the Company maintains various bank accounts in Thailand and Israel, with some level of insurance. We perform periodic evaluations of the relative credit standing of financial institutions. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company's financial condition, results of operations, and cash flows.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We perform credit evaluations of our customers’ financial condition and require no collateral from our customers. We maintain an allowance for doubtful accounts receivable based upon the expected collectability of accounts receivable balances.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#222222;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company generates revenue as follows:</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#222222;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">•</span><span style="color:#222222;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">selling of advertising services which generate revenue from advertisements placed on the Company’s owned and managed sites, as well as from advertisements placed on partner websites, for which the Company earns a share of the revenue;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#222222;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">•</span><span style="color:#222222;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">generating advertising services revenue from facilitating the real-time buying and selling of advertisements at scale between networks of buyers, known as DSPs and sellers known as SSPs;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">serving advertisers and agencies by providing access to premium inventory, leveraging data to optimize programmatic campaigns, where revenue is derived from the planning and execution of creative and media marketing campaigns; and</span></div>•providing primary research, secondary research, competitive intelligence and expert insight to address customer's strategic issues, where revenue is primarily derived from providing a single integrated service for research.
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
586000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15225000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3585000 usd
CY2023Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
161000 usd
CY2022Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
49000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-27000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
222000 usd
CY2023Q2 bmtm Number Of Customers Exceeding10 Revenue
NumberOfCustomersExceeding10Revenue
1 customer
CY2022Q2 bmtm Number Of Customers Exceeding10 Revenue
NumberOfCustomersExceeding10Revenue
1 customer
bmtm Number Of Customers Exceeding10 Revenue
NumberOfCustomersExceeding10Revenue
1 customer
bmtm Number Of Customers Exceeding10 Revenue
NumberOfCustomersExceeding10Revenue
1 customer
CY2023Q2 bmtm Number Of Customers Exceeding10 Receivable
NumberOfCustomersExceeding10Receivable
2 customer
CY2022 bmtm Number Of Customers Exceeding10 Receivable
NumberOfCustomersExceeding10Receivable
1 customer
CY2023Q2 bmtm Number Of Vendors Exceeding10 Revenue
NumberOfVendorsExceeding10Revenue
0 vendor
CY2022 bmtm Number Of Vendors Exceeding10 Revenue
NumberOfVendorsExceeding10Revenue
2 vendor
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Reclassification</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2022, reclassification of certain accounts has been made to previously reported amounts to conform to their treatment to the current period. Specifically, the Company identified a reclassification of commissions from general and administrative expenses to cost of revenue on the consolidated statements of operations, reclassification between note receivable to prepaid expense and other current assets, website acquisition assets to intangible assets, as well as a reclassification between accrued expenses to other liabilities on the consolidated balance sheets. These reclassifications had no impact on the previously reported net loss for the three and six months ended June 30, 2022.</span></div>
CY2023Q2 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
11959000 usd
CY2022Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
3447000 usd
CY2023Q2 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
3757000 usd
CY2022Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
724000 usd
CY2023Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
15716000 usd
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
4171000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
491000 usd
CY2023Q2 us-gaap Prepaid Insurance
PrepaidInsurance
443000 usd
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
1000 usd
CY2023Q2 bmtm Prepaid Consulting Service Agreements
PrepaidConsultingServiceAgreements
95000 usd
CY2022Q4 bmtm Prepaid Consulting Service Agreements
PrepaidConsultingServiceAgreements
285000 usd
CY2023Q2 bmtm Prepaid Software
PrepaidSoftware
107000 usd
CY2022Q4 bmtm Prepaid Software
PrepaidSoftware
176000 usd
CY2023Q2 us-gaap Deposits Assets
DepositsAssets
187000 usd
CY2022Q4 us-gaap Deposits Assets
DepositsAssets
137000 usd
CY2023Q2 bmtm Prepaid Subscriptions
PrepaidSubscriptions
638000 usd
CY2022Q4 bmtm Prepaid Subscriptions
PrepaidSubscriptions
0 usd
CY2023Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
140000 usd
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
138000 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1610000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
737000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
187000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
137000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1423000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
600000 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2362000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
389000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2148000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
349000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
214000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
40000 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
39000 usd
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
8000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
46000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
12000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
19556000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4510000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
728000 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
390000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1100000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
786000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1650000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
3300000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2539000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1904000 usd
CY2023Q2 bmtm Finite Lived Intangible Asset Expected Amortization After Year Three
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearThree
10163000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
19556000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
19645000 usd
us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
1291000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
20936000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
11139000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8585000 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
644000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
380000 usd
CY2023Q2 bmtm Publisher Cost Current
PublisherCostCurrent
763000 usd
CY2022Q4 bmtm Publisher Cost Current
PublisherCostCurrent
559000 usd
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
767000 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
677000 usd
CY2023Q2 bmtm Subcontractor Current
SubcontractorCurrent
1270000 usd
CY2022Q4 bmtm Subcontractor Current
SubcontractorCurrent
0 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
619000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
116000 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
15202000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
10317000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
57000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
38000 usd
CY2023Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
692000 usd
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
692000 usd
CY2023Q2 bmtm Project Advance Expense Current
ProjectAdvanceExpenseCurrent
2696000 usd
CY2022Q4 bmtm Project Advance Expense Current
ProjectAdvanceExpenseCurrent
0 usd
CY2023Q2 us-gaap Litigation Reserve Current
LitigationReserveCurrent
1338000 usd
CY2022Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
1107000 usd
CY2023Q2 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
5000 usd
CY2022Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
1000 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4788000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1838000 usd
CY2020Q2 bmtm Repayment Of Loans Percentage
RepaymentOfLoansPercentage
0.025
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
250000 usd
bmtm Repayment Of Loans Percentage
RepaymentOfLoansPercentage
0.025
bmtm Debt Instrument Number Of Amendments
DebtInstrumentNumberOfAmendments
18 amendment
CY2023Q2 us-gaap Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
161000 usd
us-gaap Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
161000 usd
CY2022Q2 us-gaap Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
0 usd
us-gaap Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
0 usd
CY2023Q2 us-gaap Debt Instrument Fee Amount
DebtInstrumentFeeAmount
140000 usd
CY2023Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
4048000 usd
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
4860000 usd
CY2023Q2 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
53061000 usd
CY2022Q4 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
25101000 usd
CY2023Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
57109000 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
29961000 usd
CY2023Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
7041000 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
3148000 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
64150000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
33109000 usd
CY2023Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
33109000 usd
CY2022Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
26334000 usd
CY2023Q2 bmtm Debt Instruments Additional Draw
DebtInstrumentsAdditionalDraw
27816000 usd
CY2022Q4 bmtm Debt Instruments Additional Draw
DebtInstrumentsAdditionalDraw
3050000 usd
CY2023Q2 bmtm Debt Instrument Exit And Other Fee
DebtInstrumentExitAndOtherFee
818000 usd
CY2022Q4 bmtm Debt Instrument Exit And Other Fee
DebtInstrumentExitAndOtherFee
621000 usd
CY2023Q2 bmtm Debt Instrument Interest Capitalized
DebtInstrumentInterestCapitalized
2407000 usd
CY2022Q4 bmtm Debt Instrument Interest Capitalized
DebtInstrumentInterestCapitalized
3104000 usd
CY2023Q2 us-gaap Debt Instrument Repurchase Amount
DebtInstrumentRepurchaseAmount
31041000 usd
CY2022Q4 us-gaap Debt Instrument Repurchase Amount
DebtInstrumentRepurchaseAmount
6775000 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
64150000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
33109000 usd
bmtm Debt Instrument Number Of Amendments
DebtInstrumentNumberOfAmendments
18 amendment
us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
35500000 usd
bmtm Adjustments To Additional Paid In Capital Extinguishment Of Debt
AdjustmentsToAdditionalPaidInCapitalExtinguishmentOfDebt
670000 usd
CY2023Q2 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
35991000 usd
CY2023Q2 bmtm Line Of Credit Facility Agency Fee
LineOfCreditFacilityAgencyFee
140000 usd
CY2023Q2 bmtm Line Of Credit Facility Exit Fee
LineOfCreditFacilityExitFee
4483000 usd
CY2023Q2 us-gaap Shares Issued
SharesIssued
34051993 shares
CY2021 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
6000000 usd
CY2021 us-gaap Dividends Preferred Stock
DividendsPreferredStock
500000 usd
CY2023Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
1707000 usd
CY2022Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
829000 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
2570000 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
1386000 usd
CY2023Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
536000 usd
CY2022Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
331000 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
837000 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
608000 usd
CY2023Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
2243000 usd
CY2022Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
1160000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
3407000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
1994000 usd
CY2020Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.015
CY2020Q3 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.18
CY2022Q3 bmtm Legal Settlement Period
LegalSettlementPeriod
P50M
CY2023Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
572000 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1926000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12616000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5717000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14114000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9176000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12616000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5717000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14114000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9176000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
737000 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1162000 usd
bmtm Deferred Revenue Invoice Amount
DeferredRevenueInvoiceAmount
1561000 usd
CY2022 bmtm Deferred Revenue Invoice Amount
DeferredRevenueInvoiceAmount
588000 usd
us-gaap Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
4754000 usd
CY2022 us-gaap Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
0 usd
bmtm Contract With Customer Liability Revenue Recognized Including Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance
2189000 usd
CY2022 bmtm Contract With Customer Liability Revenue Recognized Including Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance
1013000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4863000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
737000 usd
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
21401993 shares
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1926000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6517660 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.12
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y9M18D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
535000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.16
bmtm Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2
P9Y2M12D
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
70000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
869375 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.01
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
156500 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.10
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5956785 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.14
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y2M12D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1835897 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.29
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y3M18D
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
4120888 shares
bmtm Share Based Compensation Arrangement By Share Based Payment Award Options Unvested Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedWeightedAverageExercisePrice
0.07
bmtm Sharebased Compensation Arrangement By Sharebased Payment Award Options Unvested Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedWeightedAverageRemainingContractualTerm1
P9Y
bmtm Sharebased Compensation Arrangement By Sharebased Payment Award Options Unvested Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedIntrinsicValue1
0 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
167588 usd
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
4.99
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
4.12
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0359
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0270
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q2 bmtm Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate
0
CY2022Q2 bmtm Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
535000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
4845433 shares
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
338000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
333000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
57000 usd
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
40000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
81000 usd
CY2022Q2 us-gaap Payments For Rent
PaymentsForRent
44000 usd
us-gaap Payments For Rent
PaymentsForRent
92000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
338000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
367000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
57000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
38000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
276000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
319000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
333000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
357000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
57000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
38000 usd
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
21401993 shares
CY2023Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
70000 shares
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000 usd
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
70000 shares
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000 usd
CY2023Q2 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
0 shares
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
0 usd
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
190000 shares
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
31000 usd
CY2023Q2 us-gaap Stock Issued During Period Shares Period Increase Decrease
StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
21471993 shares
CY2023Q2 bmtm Stock Issued During Period Common Stock Value Period Increase Decrease
StockIssuedDuringPeriodCommonStockValuePeriodIncreaseDecrease
1927000 usd
us-gaap Stock Issued During Period Shares Period Increase Decrease
StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
21661993 shares
bmtm Stock Issued During Period Common Stock Value Period Increase Decrease
StockIssuedDuringPeriodCommonStockValuePeriodIncreaseDecrease
1958000 usd
us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
174253 shares
us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
174253 shares
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
279000 usd
us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
174253 shares
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
279000 usd
CY2021 bmtm Number Of Shareholders
NumberOfShareholders
3 shareholder
CY2023Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
31173316 shares
CY2023Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
23555000 usd
bmtm Class Of Warrant Or Right Expired In Period
ClassOfWarrantOrRightExpiredInPeriod
4825000 shares
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
35998316 shares
CY2022Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
26692000 usd
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
172106629 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
149984636 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
171281454 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
149159461 shares
CY2023Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
825175 shares
CY2022Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
825175 shares
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-6071000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1458000 usd
us-gaap Net Income Loss
NetIncomeLoss
-9867000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3575000 usd
CY2023Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
0 usd
CY2022Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1000 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
0 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
2000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6071000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1459000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9867000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3577000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
166779390 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
166779390 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
149159461 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
149159461 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
158291304 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
158291304 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
149130579 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
149130579 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2023Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
31173316 shares
bmtm Debt Instrument Number Of Amendments
DebtInstrumentNumberOfAmendments
18 acquiredbusiness
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023Q2 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0 usd
us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0 usd
CY2022Q2 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0 usd
us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
bmtm-20230630_pre.xml Edgar Link unprocessable
0001628280-23-029384-index-headers.html Edgar Link pending
0001628280-23-029384-index.html Edgar Link pending
0001628280-23-029384.txt Edgar Link pending
0001628280-23-029384-xbrl.zip Edgar Link pending
bmtm-20230630.htm Edgar Link pending
bmtm-20230630.xsd Edgar Link pending
bmtm-20230630_g1.jpg Edgar Link pending
bmtm-2023x0630x10qxexx103.htm Edgar Link pending
bmtm-2023x0630x10qxexx311.htm Edgar Link pending
bmtm-2023x0630x10qxexx312.htm Edgar Link pending
bmtm-2023x0630x10qxexx321.htm Edgar Link pending
bmtm-2023x0630x10qxexx322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
bmtm-20230630_cal.xml Edgar Link unprocessable
bmtm-20230630_def.xml Edgar Link unprocessable
bmtm-20230630_lab.xml Edgar Link unprocessable
bmtm-20230630_htm.xml Edgar Link completed
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending